You will be redirected to https://www.worldscientific.com/apbn to view or purchase the issue PDF.
EDITORIAL
BioBoard
JAPAN • Study notes widening disease transmission by monkeys
MALAYSIA • Drug-resistant malaria threatens control programs
SINGAPORE • Novel gene predicts both breast cancer relapse and response to chemotherapy • New drug formulations to boost fight against respiratory illnesses and antibiotic-resistant superbugs • Zebrafish genes linked to human respiratory diseases • Singapore researchers discover a gene that increases incidence of acute myelogenous leukemia • Scientists develop green tea-based 'missiles' to kill cancer cells more effectively
UNITED STATES • Large study reveals new genetic variants that raise risk for prostate cancer • Math model designed to replace invasive kidney biopsy for lupus patients • Mayo Clinic researchers reveal pathway that contributes to Alzheimer’s disease • Immunotherapy combination demonstrates superior anti-cancer activity
EYE ON CHINA • Milestone Scientific and Milestone China form new dermatological joint venture • BGI and The Vancouver Prostate Centre to create joint research laboratory for advancement of translational cancer research • BGI Tech, DLF-Trifolium A/S, and Aarhus University applying genomic selection methods to enhance forage grass varieties • Ioxus to be incorporated in China as Ioxus (Shanghai) Clean Energy Technology • Tsinghua and UC Berkeley launch research and graduate education partnership • Altor BioScience and Shenzhen Beike Biotechnology enter license agreement for immunotherapeutic ALT-803 in China • 3SBio Inc. obtains exclusive licenses to develop and market JenKem's PEG-Irinotecan in China
FEATURES • Site Mapping the Innovative Way • The Art of Site Selection – How Sites Without Trials Experience Could Help Bolster Study Performance • Become Greats through GREATS • Unraveling Heart Failure: Looking at an Asian Phenotype • Recognizing Opportunities Amidst Biopharma Challenges in China
PEOPLE WATCH • Tackling Resistance with RNA
INSIDE INDUSTRY • Innovation in Academic Medicine • Merck Serono awards Grant for Growth Innovation (GGI) for the first time • National Cancer Institute awards KIYATEC nearly $2M to fund 3D breast cancer, 3D brain cancer micro-tumor development • Frost & Sullivan honors 2014 Growth, Innovation & Leadership Award winners • Abcam licenses novel Ceefourin inhibitors of multidrug resistance protein 4 from Australia’s Children’s Cancer Institute • Daiichi Sankyo further expands TaNeDS collaborative drug discovery program in Europe • Veolia Water Technologies South-East Asia to provide advanced water solutions for Tun Razak Exchange Project in Malaysia • Biocept and Rosetta Genomics collaborate to evaluate microRNAs from circulating tumor cells • Biocept expands collaboration with MD Anderson Cancer Center
• CONFERENCE CALENDAR